Apollo Hospitals Enterprise Ltd (AHEL), one of the market’s top players, has seen tremendous growth in the Indian healthcare sector over the past few years. AHEL is a privately held business that offers medical services and manages pharmacies, clinics, and hospitals in India. Investors have been keenly watching AHEL’s financial results and growth prospects since the company’s share price has steadily increased over the years. Many people are unsure of what the future holds for the share price of AHEL given that the healthcare sector is anticipated to grow even more in the upcoming years. In this article, we’ll look at the variables that could have an impact on AHEL’s share price projection between 2023 and 2030 and offer some insights into the company’s potential for growth.
CLICK HERE FOR MORE:
UCO BANK SHARE PRICE TARGET 2023 TO 2030: CAN UCO REACH 100 INR?
APOLLO IN RECENT NEWS
- Apollo Hospital’s stock price declines in tandem with a 734.25-point drop in Sensex.
- Over the next four years, Apollo Hospitals plans to increase its bed capacity by 2,000 across four major cities.
- Demonstrations erupt prior to the transfer of IPGISSH to Apollo Hospitals.
APOLLO SHARE PRICE TARGET 2023
|APOLLO SHARE PRICE TARGET 2023||Maximum Price||Minimum Price|
Apollo Hospitals Enterprise Limited (AHEL) has a positive outlook for 2023, as indicated by the share price predictions in the table above. Despite some fluctuations throughout the year, AHEL is expected to finish the year on an overall uptrend. The maximum share price for December 2023 is predicted to be ₹7,718.95, which represents an impressive growth percentage from the minimum price in March 2023 of approximately 132%. The share price appears to be bullish in the second half of the year, with July 2023 seeing a high of ₹5,695.80 and September 2023 projected to see a high of ₹6,578.65. These trends suggest that AHEL may be a strong investment opportunity in the healthcare sector for the coming year.
APOLLO SHARE PRICE TARGET 2024
|APOLLO SHARE PRICE TARGET 2024||Maximum Price||Minimum Price|
Apollo Hospitals Enterprise Limited (AHEL) is expected to continue its bullish run into 2024, according to share price predictions for the year. The maximum share price target for the year is predicted to be ₹10,806.86 in December 2024, which represents an impressive growth percentage from the minimum price in May 2024 of approximately 93%. AHEL’s share price is projected to reach new highs in October and November 2024, with targets of ₹10,090.44 and ₹10,594.96, respectively. Despite some slight fluctuations in the first half of the year, AHEL is expected to end 2024 on an overall uptrend. The minimum share price target for the year is predicted to be ₹5,600.20 in May 2024. These projections suggest that AHEL may continue to be a strong investment opportunity in the healthcare sector, with a potential for significant returns in the coming years.
ICICI BANK SHARE PRICE TARGET 2023 TO 2030: CAN ICICI REACH 3000 INR?
APOLLO SHARE PRICE TARGET 2025
|APOLLO SHARE PRICE TARGET 2025||Maximum Price||Minimum Price|
Apollo Hospitals Enterprise Limited (AHEL) is expected to continue its bullish trend into 2025, with share price predictions for the year indicating potential for further growth. The maximum share price target for 2025 is projected to be ₹13,108.90 in December, which represents a significant growth percentage from the minimum price in May of approximately 75%. AHEL’s share price is expected to reach new highs in October and November 2025, with targets of ₹12,011.08 and ₹12,851.86, respectively. Although there may be some slight fluctuations in the first half of the year, overall, AHEL is predicted to continue its uptrend. The minimum share price target for the year is projected to be ₹7,606.97 in May 2025. These share price predictions suggest that AHEL may continue to be a strong investment opportunity in the healthcare sector, with the potential for significant returns in the coming years.
APOLLO SHARE PRICE TARGET 2026 TO 2030
|APOLLO SHARE PRICE TARGET BY||Maximum Price||Minimum Price|
Based on the provided data, the maximum and minimum share price targets for Apollo Hospital for the years 2026 to 2030 are as follows: In 2026, the maximum and minimum prices are expected to be ₹9,176.23 and ₹6,423.36, respectively. In 2027, the prices are expected to decrease, with a maximum of ₹7,799.79 and a minimum of ₹5,459.85. However, in 2028, there is a significant increase in the share price, with a maximum of ₹14,039.63 and a minimum of ₹9,827.74. This trend is expected to continue in 2029, with a maximum price of ₹28,839.57 and a minimum of ₹20,187.70. In 2030, the maximum price is expected to be ₹32,116.79, while the minimum price is expected to be ₹22,481.76. It is important to note that these figures are based on historical trends and future market conditions can significantly affect the actual share prices.
CLICK HERE FOR MORE:
BANDHAN BANK SHARE PRICE TARGET 2023 TO 2030: CAN BANDHAN BANK REACH 1000 INR?
FINANCIAL STRENGTH OF APOLLO (2018 TO 2022)
|ANNUAL||FY 2022||FY 2021||FY 2020||FY 2019||FY 2018|
|Total Revenue Growth (%)||39.00||-5.93||16.84||16.59||13.70|
|Total Expenses Growth (%)||28.84||-3.40||16.55||14.46||14.17|
|Profit after Tax (PAT)||1,055.60||150.40||454.80||236.05||117.42|
|PAT Growth (%)||601.86||-66.93||92.67||101.03||-46.87|
|Operating Profit Margin (%)||11.33||5.76||8.84||7.27||5.65|
|Net Profit Margin (%)||7.19||1.42||4.04||2.45||1.42|
|Basic EPS (₹)||73.42||10.74||32.70||16.97||8.44|
Apollo Hospital’s financial statement for the last five years indicates consistent growth in revenue and profit, with some fluctuations in between. The company’s total revenue saw a steady rise from FY2018 to FY2020, with a maximum growth of 16.84% in FY2020. However, the revenue declined by 5.93% in FY2021 due to the impact of the pandemic. The revenue growth bounced back in FY2022, with an impressive growth rate of 39%. Despite the pandemic, the company managed to maintain its total expenses under control, with a minimum growth of -3.40% in FY2021. The Profit after Tax (PAT) saw a significant increase of 601.86% in FY2022, primarily due to the revenue growth and effective cost management. The PAT had a steep decline in FY2021, primarily due to the pandemic’s impact. However, it bounced back in FY2022, crossing the ₹1000 crore mark. The company’s Operating Profit Margin and Net Profit Margin also saw a steady increase over the years, indicating effective cost management. Overall, Apollo Hospital’s financial statement reflects consistent growth with some fluctuations, primarily due to external factors like the pandemic.
Emergency Credit Line Guarantee Scheme
The maximum share price target of Apollo Hospital in 2026 is Rs. 9176.23
The maximum share price target of Apollo Hospital in 2027 is Rs. 7799.79
The maximum share price target of Apollo Hospital in 2028 is Rs.14039.63
The maximum share price target of Apollo Hospital in 2029 is Rs. 28839.57
The maximum share price target of Apollo Hospital in 2030 is Rs. 32116.79
CONCLUSION: APOLLO HOSPITALS
According to Apollo Hospitals’ financial filings over the previous five years, the business has experienced tremendous growth in terms of sales, profit, and PAT. From FY 2018 through FY 2022, revenue rose, reaching a peak growth of 39% in FY 2022. With an increase of 601.86% in FY 2022, the PAT growth rate is similarly high. Nonetheless, the profit growth % is erratic, with a negative growth rate in FY 2018 and FY 2021.
It may be said that Apollo Hospitals has fared well recently based on the general growth trend in sales, PAT, and operating profit margin. But, a number of additional factors, such as market volatility, industry competitiveness, and prevailing economic conditions, also have an impact on share prices.